New York State Common Retirement Fund Bellerophon Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.75 - $4.86 $138 - $179	-37 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.83 - $5.65 $1,007 - $1,485	-263 Reduced 87.67%	37 $0
Q3 2020 Nov 05, 2020	SELL	$9.27 - $13.79 $71,379 - $106,183	-7,700 Reduced 96.25%	300 $3,000
Q2 2020 Aug 07, 2020	BUY	$9.43 - $20.28 $75,440 - $162,240	8,000 New	8,000 $100,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $95.5K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.